Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 16.20
+0.02 (0.12%)
May 7, 2026, 4:08 PM HKT
Zai Lab Employees
Zai Lab had 1,784 employees as of December 31, 2025. The number of employees decreased by 85 or -4.55% compared to the previous year.
Employees
1,784
Change (1Y)
-85
Growth (1Y)
-4.55%
Revenue / Employee
2.01M HKD
Profits / Employee
-765.85K HKD
Market Cap
18.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,784 | -85 | -4.55% | 1,784 | 0 |
| Dec 31, 2024 | 1,869 | -306 | -14.07% | 1,869 | 0 |
| Dec 31, 2023 | 2,175 | 139 | 6.83% | 2,175 | 0 |
| Dec 31, 2022 | 2,036 | 85 | 4.36% | 2,036 | 0 |
| Dec 31, 2021 | 1,951 | 757 | 63.40% | 1,951 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genscript Biotech | 6,165 |
| Keymed Biosciences | 1,625 |
| InnoCare Pharma | 1,176 |
| Everest Medicines | 812 |
| Ascentage Pharma Group International | 767 |
| CARsgen Therapeutics Holdings | 355 |
| Duality Biotherapeutics | 231 |
| Ascletis Pharma | 208 |
Zai Lab News
- 1 hour ago - Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates - Business Wire
- 15 days ago - Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Business Wire
- 16 days ago - Zai Lab Transcript: Study update - Transcripts
- 17 days ago - ZLAB: Zai Lab Unveils Promising Data for ZL-1503 in Treating Atopic Diseases - GuruFocus
- 18 days ago - Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases - Business Wire
- 19 days ago - ZLAB: Zai Lab Showcases Promising Clinical Data for Cancer Treatment - GuruFocus
- 19 days ago - Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas - Business Wire
- 21 days ago - Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas - GlobeNewsWire